Arcus Biosciences Inc Logo

Arcus Biosciences Inc (RCUS): Eigentümerstruktur

Takani Score ?
27.1

Preis (11.09.2026)52W Hoch52W Tief
24,59 US Dollar31,735 US Dollar11,3 US Dollar
Analysten KonsensBuyOutperformHoldUnderperformSell
38,75 US Dollar83200
Externe Analystenschätzungen (Quelle: EODHD) – keine Anlageempfehlung von Takani.
#SharesShort [%]Short Ratio
127.333.37616,7611,21

Eigentümerstruktur

Analyse der Aktionärsstruktur und institutionellen Investoren

Unternehmensdaten

Grundlegende Informationen

Grunddaten

Name Arcus Biosciences Inc
Mitarbeiter 601
Handelsplatz NYSE
Ticker Symbol RCUS
IPO Datum 2018-03-15
Adresse 3928 Point Eden Way, Hayward, CA, United States, 94545

Unternehmensführung

RangNamePosition
1Dr. Terry J. Rosen Ph.D.Co-Founder, Chairman & CEO
2Dr. Juan Carlos Jaen Ph.D.Co- Founder & President
3Mr. Robert C. Goeltz IIPrincipal Financial Officer & CFO
4Dr. Richard A. Markus M.D., Ph.D.Chief Medical Officer
5Dr. K. Christopher Garcia Ph.D.Co-Founder & Member of Scientific Advisory Board
6Mr. Alexander Azoy CPAChief Accounting Officer
7Dr. Jonathan Yingling Ph.D.Chief Scientific Officer
8Pia EavesVice President of Investor Relations & Strategy
9Ms. Carolyn C. Tang J.D.General Counsel & Corporate Secretary
10Holli KolkeyVice President of Corporate Communications

Aktionärsverteilung

Aufteilung der Investoren

Größte Investoren

RangInhaberAnteileWert
1BlackRock Inc11,96%0,37 Mrd. USD
2Wellington Management Company LLP4,63%0,15 Mrd. USD
3State Street Corp4,25%0,13 Mrd. USD
4Suvretta Capital Management, LLC3,95%0,12 Mrd. USD
5Vanguard Portfolio Management, LLC3,36%0,11 Mrd. USD
6Vanguard Capital Management, LLC3,03%0,10 Mrd. USD
7Woodline Partners LP2,97%0,09 Mrd. USD
8Marshall Wace Asset Management Ltd2,95%0,09 Mrd. USD
9Citadel Advisors Llc2,46%0,08 Mrd. USD
10Siren, L.L.C.2,36%0,07 Mrd. USD
11Geode Capital Management, LLC1,77%0,06 Mrd. USD
12Fisher Asset Management, LLC1,68%0,05 Mrd. USD
13BNP Paribas Investment Partners SA1,30%0,04 Mrd. USD
14Samlyn Capital, LLC1,22%0,04 Mrd. USD
15Dimensional Fund Advisors, Inc.1,13%0,04 Mrd. USD
16Soleus Capital Management, L.P.0,92%0,03 Mrd. USD
17FMR Inc0,92%0,03 Mrd. USD
18Morgan Stanley - Brokerage Accounts0,87%0,03 Mrd. USD
19The Goldman Sachs Group Inc0,79%0,03 Mrd. USD
20Sofinnova Ventures0,72%0,02 Mrd. USD